PROKIDNEY CP (PROK)
(Delayed Data from NSDQ)
$1.70 USD
+0.14 (9.00%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.70 +0.01 (0.29%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for ProKidney Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -135.45 | -148.14 | -2.32 | -26.75 | NA |
Depreciation/Amortization & Depletion | 3.85 | 3.04 | 0.00 | 0.96 | NA |
Net Change from Assets/Liabilities | 16.67 | -6.46 | 1.12 | -0.13 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 24.85 | 74.47 | 0.00 | 0.73 | NA |
Net Cash From Operating Activities | -90.07 | -77.09 | -1.21 | -25.18 | NA |
Property & Equipment | -34.20 | -1.85 | 0.00 | -5.46 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | -295.79 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.11 | -250.00 | 0.00 | NA |
Net Cash from Investing Activities | -329.98 | -1.74 | -250.00 | -5.46 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -9.50 | 0.00 | 245.60 | 0.00 | NA |
Issuance (Repayment) of Debt | -0.05 | -0.03 | -0.39 | -0.01 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.40 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 548.55 | 6.04 | 20.00 | NA |
Net Cash from Financing Activities | -9.55 | 548.52 | 251.65 | 19.99 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -429.60 | 469.69 | 0.44 | -10.65 | NA |
Cash at Beginning of Period | 490.25 | 20.56 | 0.00 | 15.23 | NA |
Cash at End of Period | 60.65 | 490.25 | 0.44 | 4.58 | NA |
Diluted Net EPS | -0.57 | -0.23 | -0.11 | NA | NA |
Fiscal Year End for ProKidney Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -73.80 | -35.33 | -135.45 | -113.72 | -71.73 |
Depreciation/Amortization & Depletion | 2.37 | 1.10 | 3.85 | 2.71 | 1.70 |
Net Change from Assets/Liabilities | -13.33 | -5.81 | 16.67 | 12.77 | 6.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 11.82 | 5.39 | 24.85 | 33.56 | 22.24 |
Net Cash From Operating Activities | -72.94 | -34.65 | -90.07 | -64.69 | -40.91 |
Property & Equipment | -1.60 | -0.96 | -34.20 | -32.63 | -4.69 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 88.57 | 59.36 | -295.79 | -201.51 | -201.08 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 86.97 | 58.40 | -329.98 | -234.14 | -205.77 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 139.86 | 0.00 | -9.50 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -0.03 | -0.01 | -0.05 | -0.04 | -0.03 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 139.83 | -0.01 | -9.55 | -0.04 | -0.03 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 153.86 | 23.74 | -429.60 | -298.86 | -246.70 |
Cash at Beginning of Period | 60.65 | 60.65 | 490.25 | 490.25 | 490.25 |
Cash at End of Period | 214.51 | 84.39 | 60.65 | 191.39 | 243.55 |
Diluted Net EPS | -0.16 | -0.16 | -0.09 | -0.18 | -0.14 |